The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic esophageal and gastroesophageal carcinoma with dysphagia: A single arm phase 2 clinical trial, PALEO.
 
Fiona Day
Consulting or Advisory Role - Amgen
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Varian Medical Systems
 
Swetha Sridharan
Employment - GenesisCare (I)
 
Michael Michael
Honoraria - Novartis; SAM Nordic
Consulting or Advisory Role - Ipsen; Isotopen Technologien; Merck; Merck Sharp & Dohme; PanTher Therapeutics
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Louise Christophersen
Employment - Australian Gastro-Intestinal Trials Group
Stock and Other Ownership Interests - Dimerix (I); IXC (I)
 
Melissa M. Moore
Consulting or Advisory Role - Merck; Takeda
 
Melissa A. Eastgate
Honoraria - The Limbic
Travel, Accommodations, Expenses - Novartis
 
Stephen Thompson
No Relationships to Disclose
 
ANGELA MWEEMPWA
No Relationships to Disclose
 
Christopher Oldmeadow
No Relationships to Disclose
 
Allison Fraser
Stock and Other Ownership Interests - CSL Limited
 
Jarad Martin
Employment - GenesisCare; SeeTreat
Stock and Other Ownership Interests - GenesisCare; Margin-Clear
Honoraria - Abbvie
Consulting or Advisory Role - Ferring; Janssen Oncology; Sanofi
Research Funding - Ipsen (Inst); Mundipharma; Varian Medical Systems